Effect of PGI2 and stable endoperoxide analogues on cyclic nucleotide levels in clonal cell lines of CNS origin.
D001254:Astrocytoma / Q000378:metabolism*; D002460:Cell Line; D000242:Cyclic AMP / Q000378:metabolism; D006152:Cyclic GMP / Q000378:metabolism; D004305:Dose-Response Relationship, Drug; D011464:Epoprostenol / Q000494:pharmacology*; D009374:Neoplasms, Experimental / Q000378:metabolism; D009447:Neuroblastoma / Q000378:metabolism*; D009712:Nucleotides, Cyclic / Q000378:metabolism*; D011450:Prostaglandin Endoperoxides, Synthetic / Q000494:pharmacology*; D011453:Prostaglandins / Q000494:pharmacology*
D009712:Nucleotides, Cyclic; D011450:Prostaglandin Endoperoxides, Synthetic; D011453:Prostaglandins; D011464:Epoprostenol; D000242:Cyclic AMP; D006152:Cyclic GMP